Interprofessional Issues Novel, Interprofessional Approach Enhances Bed Assignments for Individuals on Antineoplastic Drugs in a Hospital Setting August 22, 2024
Nurse Empowerment Sharing Our Stories Supports, Celebrates, and Advances the Nursing Profession July 04, 2024
Trending Topics Research Safety Nurse Well-Being Drug Reference Sheets ONS Congress Specific Populations View All Topics
U.S. Food and Drug Administration (FDA) FDA Grants Accelerated Approval to Tovorafenib for Patients With Relapsed or Refractory BRAF-Altered Pediatric Low-Grade Glioma April 24, 2024
U.S. Food and Drug Administration (FDA) FDA Approves Nogapendekin Alfa Inbakicept-Pmln for BCG-Unresponsive Non–Muscle Invasive Bladder Cancer April 23, 2024
U.S. Food and Drug Administration (FDA) FDA Approves Alectinib as Adjuvant Treatment for ALK-Positive Non-Small Cell Lung Cancer April 18, 2024
Cancer Research LGBTQ+ Individuals Have Higher Rates of Cancer Because of Disparities in Modifiable Risk Factors, ACS Says April 18, 2024
Advanced Practice Nursing (APRN) Nurse-Led Innovations Are Shaping the Future of Oncology Care April 16, 2024
Nurse Navigator What the New CMS Reimbursement for Principal Illness Navigation Means for Oncology Nurses April 15, 2024
Cancer Research Psychological Distress Linked to Quality of Life and Overall Survival in Patients Receiving AlloHSCT April 11, 2024
Specific Populations Specialized Center Customizes Care for Growing Population of Patients With Young-Onset CRC April 10, 2024
Integrative Medicine Does Dance/Movement Therapy Affect Outcomes for Pediatric Patients With Cancer? April 09, 2024
U.S. Food and Drug Administration (FDA) FDA Grants Accelerated Approval to Fam-Trastuzumab Deruxtecan-Nxki for Unresectable or Metastatic HER2-Positive Solid Tumors April 05, 2024
Specific Populations 6 Strategies for Talking to Kids About a Family Member’s Cancer Diagnosis April 04, 2024
Survivorship Patients With Fertility Concerns May Face Barriers to Fertility Preservation April 03, 2024
ONS Leadership Working Together, Passionate ONS Volunteers Are Transforming Cancer Care April 01, 2024
Nurse Well-Being Critical Event Debriefings Can Reduce Oncology Nurses’ Risk of Compassion Fatigue and Burnout March 28, 2024
U.S. Food and Drug Administration (FDA) FDA Announces Amneal Pharmaceuticals’ Nationwide Recall of Vancomycin Hydrochloride for Oral Solution USP, 250 mg/5 ml March 27, 2024
Specific Populations LGB AYA Patients With Cancer Have High Burden of Chronic Conditions in Survivorship March 27, 2024
U.S. Food and Drug Administration (FDA) FDA Fully Approves Mirvetuximab Soravtansine-Gynx for FR Alpha–Positive, Platinum-Resistant Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer March 22, 2024
U.S. Food and Drug Administration (FDA) FDA Approves Safety Labeling Changes for Fluorouracil Injection Products March 22, 2024
Genetics & Genomics AI Multiple Myeloma Model Predicts Individual Risk, Outcomes, and Genomic Implications March 20, 2024
U.S. Food and Drug Administration (FDA) FDA Grants Accelerated Approval to Ponatinib With Chemotherapy for Newly Diagnosed Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia March 19, 2024
Cancer Screening As Colorectal Cancer Incidence Increases in Younger Patients, USPSTF Issues New Screening Guidelines. Here’s How Nurses Can Encourage Uptake March 19, 2024
Integrative Medicine Mind-Body Practices Reduce Cancer-Related Symptoms and Improve Patients’ Mental Health March 13, 2024
Oncology Nurse-Patient Relationship Stop Stigma and Discrimination in Health Care to Improve Equity and Patient Outcomes March 12, 2024
U.S. Food and Drug Administration (FDA) FDA Grants Accelerated Approval to Zanubrutinib for Relapsed or Refractory Follicular Lymphoma March 08, 2024
U.S. Food and Drug Administration (FDA) FDA Approves Nivolumab With Cisplatin and Gemcitabine for Unresectable or Metastatic Urothelial Carcinoma March 07, 2024
U.S. Food and Drug Administration (FDA) FDA Announces Smiths Medical ASD Inc.’s Recall of Medfusion Model 3500 Syringe Pump March 06, 2024
U.S. Food and Drug Administration (FDA) FDA Approves Inotuzumab Ozogamicin for Pediatric Patients With Acute Lymphoblastic Leukemia March 06, 2024
Symptom Management Exercise Program Improves Quality of Life in Patients With Breast Cancer—and Keeps Them Moving Daily March 06, 2024
U.S. Food and Drug Administration (FDA) FDA Approves Amivantamab-Vmjw for EGFR Exon 20 Insertion–Variant NSCLC March 01, 2024
End of Life (EOL) Writing Condolence Cards Supports Nurses as Well as Deceased Patients’ Families February 29, 2024
U.S. Food and Drug Administration (FDA) FDA Issues Safety Communication for Use of BioZorb Markers in Breast Tissue February 28, 2024
Cancer Health Disparities Community-Based Program Overcomes Barriers to Cancer Screening and Access to Care February 28, 2024
Cancer Recurrence Young Adults With Cervical Cancer Can Follow Tailored Surveillance Strategies February 21, 2024
Caregiver Support Strategies to Support Family and Friend Caregivers for Patients With Cancer February 20, 2024
Oncology Clinical Trials Informed Consent Helps Patients Understand Their Rights and Responsibilities as a Clinical Trial Participant February 16, 2024
U.S. Food and Drug Administration (FDA) FDA Grants Accelerated Approval to Lifileucel for Unresectable or Metastatic Melanoma February 16, 2024
U.S. Food and Drug Administration (FDA) FDA Approves Osimertinib With Chemotherapy for EGFR-Variant Non-Small Cell Lung Cancer February 16, 2024
U.S. Food and Drug Administration (FDA) FDA Approves Tepotinib for Metastatic Non-Small Cell Lung Cancer February 15, 2024
U.S. Food and Drug Administration (FDA) FDA Announces Smiths Medical ASD Inc.’s Recall of Medfusion Model 4000 Syringe Pump February 15, 2024